Latest filing published 17 Feb 2010 for PHARMACYCLICS INC, €133k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Glenn C. Rice: trading record in brief
Glenn C. Rice discloses dealings in Pharmacyclics Inc to SEC (Form 4). In total, 8 filings cover trades dated from 1 October 2008 to 12 February 2010.
No open-market sale appears; the market trades are 1 purchase worth €60k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 1 option exercise.
On 17 February 2010 came the latest disclosure, an option exercise for €133k in Pharmacyclics Inc. The most recent open-market purchase was published on 2 October 2008, 6,612 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Glenn C. Rice
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$0.91Common StockSEC:0001209191-10-010027:0
- 312,500 shares@ US$1.28Common StockSEC:0001209191-09-039678:0
- 37,444 shares@ US$1.28Common StockSEC:0001209191-09-038991:0
- 5,000 shares@ US$0.79Common StockSEC:0001209191-09-000730:0
- 5,000 shares@ US$0.99Common StockSEC:0001209191-08-063582:0
- 5,000 shares@ US$1.31Common StockSEC:0001209191-08-058681:0
- 40,500 shares@ US$2.03Common StockSEC:0001209191-08-054894:0Canonical exit: 30 Dec 2008 (T+90)
7 of 7 declarations
